| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |